To assess the role of USP20 in predicting resistance to CRC chemotherapy, we analyzed the expression levels of multidrug resistance–associated genes in different USP20 expression groups and the correlation between USP20 expression and drug resistance–associated gene expression. The gene discussed is USP20; the disease is colorectal carcinoma.